CEO
Expert Systems Inc
San Diego, California
Tudor I. Oprea, MD PhD, is a digital drug hunter active in artificial intelligence and knowledge management for target and drug discovery. Three drugs he co-invented reached clinical trials, including R-ketorolac, which shows promise in ovarian cancer, and LNS8801, a first-in-class orphan drug designated GPER agonist for uveal melanoma. His validated machine-learning models cover diseases, targets, and chemicals. He has made significant contributions to disease and chemical biology: systems chemical biology, lead-likeness, temporal disease trajectories, and a knowledge-based classification of human proteins. He co-created DrugCentral and Pharos, two open-source platforms. Oprea is now CEO at Expert Systems Inc. (San Diego, CA) and Professor Emeritus of Medicine at UNM Health Sciences Center (Albuquerque, NM).
Disclosure information not submitted.
Keynote: Drug Discovery and Repurposing in the LLM (Large Language Model) Era
Monday, October 21, 2024
1:30 PM – 2:30 PM MT